Literature DB >> 7166446

Prophylactic cefuroxime in total joint replacement.

S P Hughes, S Want, J H Darrell, C H Dash, M Kennedy.   

Abstract

Cefuroxime was given during operation to 95 patients undergoing 106 total joint replacements (hip 69: knee 37). Two regimes were used. Either 1 g was given intravenously with induction of anaesthesia and then two intramuscular injections of 1 g 6 and 12 h later, or 1.5 g was given intravenously with induction and two injections of 750 mg each intramuscularly 6 and 12 h later. The concentrations of cefuroxime in bone, capsule and blood were measured in 77 patients. The assays were carried out independently in two laboratories. In most instances concentrations in the bone were above the MICs for likely pathogens, even after allowing for any contaminating blood. Concentrations in synovial capsule were generally higher than in bone. After a follow-up period of 2 years, two patients developed deep infections. The overall infection rates are comparable with the best results reported in the literature using other prophylactic antibiotics or with ultra-clean air systems.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7166446     DOI: 10.1007/bf00267725

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  14 in total

1.  Standardization of hemoglobinometry. II. The hemiglobincyanide method.

Authors:  E van KAMPEN; W G ZIJLSTRA
Journal:  Clin Chim Acta       Date:  1961-07       Impact factor: 3.786

2.  Antibiotic-loaded acrylic cement.

Authors:  R A Elson; A E Jephcott; D B McGechie; D Verettas
Journal:  J Bone Joint Surg Br       Date:  1977-05

3.  Antibiotic prophylaxis in total hip replacement.

Authors:  J P Pollard; S P Hughes; J E Scott; M J Evans; M K Benson
Journal:  Br Med J       Date:  1979-03-17

4.  The long-term results of low-friction arthroplasty of the hip performed as a primary intervention.

Authors:  J Charnley
Journal:  J Bone Joint Surg Br       Date:  1972-02

5.  Total hip replacement in inflammatory hip disease using the Charnley prosthesis.

Authors:  J Harris; C D Lightowler; R C Todd
Journal:  Br Med J       Date:  1972-06-24

6.  Total hip replacement in osteoarthrosis using the Charnley prosthesis.

Authors:  R C Todd; C D Lightowler; J Harris
Journal:  Br Med J       Date:  1972-06-24

7.  Postoperative infection in total prosthetic replacement arthroplasty of the hip-joint. With special reference to the bacterial content of the air of the operating room.

Authors:  J Charnley; N Eftekhar
Journal:  Br J Surg       Date:  1969-09       Impact factor: 6.939

8.  Infection following total hip replacement and the possible prophylactic role of cephaloridine.

Authors:  S P Hughes; C H Dash; M K Benson; C A Field
Journal:  J R Coll Surg Edinb       Date:  1978-01

9.  Complications of total hip-replacement arthorplasty in patients with rheumatoid arthritis.

Authors:  R Poss; F C Ewald; W H Thomas; C B Sledge
Journal:  J Bone Joint Surg Am       Date:  1976-12       Impact factor: 5.284

10.  Infection following total hip replacement in a general hospital without special orthopaedic facilities.

Authors:  M K Benson; S P Hughes
Journal:  Acta Orthop Scand       Date:  1975-12
View more
  3 in total

1.  [Perioperative antibiotic prophylaxis in hip operations. Penetration into bone, capsule tissue and cartilage exemplified by cefuroxime].

Authors:  A Katzer; J V Wening; P Kupka; N M Meenen; K H Jungbluth
Journal:  Unfallchirurgie       Date:  1997-08

2.  [Possibilities for the use of the basic cephalosporin cefuroxime in bone surgery. Tissue levels, effectiveness and tolerance].

Authors:  R Ketterl; W Wittwer
Journal:  Infection       Date:  1993       Impact factor: 3.553

3.  A comparison of systemic cefuroxime and cefuroxime loaded bone cement in the prevention of early infection after total joint replacement.

Authors:  M McQueen; A Littlejohn; S P Hughes
Journal:  Int Orthop       Date:  1987       Impact factor: 3.075

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.